Saudi Arabia Approved Bharat Biotech’s Covaxin For Travel


The Indian Embassy in Saudi Arabia on Monday in a tweet informed that the country has approved the Bharat Biotech’s Covaxin for travel and Indian nationals vaccinated with ‘Covaxin’ can now enter the Kingdom.

“Embassy is pleased to inform that Indian nationals vaccinated with ‘Covaxin’ are now approved to enter the Kingdom. Vaccine certificates are to be uploaded at Ministry of Health website for residents and at Muqeem website for visitors.”

It is worth mentioning that earlier in November the WHO has granted approval for Emergency Use Listing of Covaxin and said that the Bharat Biotech’s vaccine was found to have 78 percent efficacy against the COVID-19 of any severity, 14 or more days after the second dose.


Saudi Arabia approved vaccines are;

  • Pfizer-BioNTech
  • Moderna
  • Oxford-AstraZeneca
  • Johnson & Johnson
  • Sinopharm
  • Sinovac and
  • Covaxin.

In recent days, Covaxin has been recognized by several countries including the United States, United Kingdom, Bahrain, Oman, Switzerland, Hong Kong, Australia, among others. It is expected to rise in the coming days.

Follow and connect with us on Facebook, Twitter, LinkedIn, Instagram and Google News for the latest travel news and updates!


Manish Khandelwal
Manish Khandelwal

Manish Khandelwal, a travel-tech enthusiast with over a decade of experience in the travel industry. Founder and Editor-in-Chief of, he's passionate about writing.

Articles: 6340